S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Sinema took Wall Street money while killing tax on investors
The Day of Financial Reckoning Is Near (Ad)
Shelling kills 1 in Ukraine; Russia wants nuke plant pledges
High oil prices help Saudi Aramco earn $88B in first half
Ship carrying grain for hungry Ethiopia leaves Ukraine
Trading Millionaire Reveals, “2008 Was My Most Profitable Year” (Ad)
Saudi Aramco's profits already $88B as oil prices stay high
Saudi oil company Aramco's half-year profits reach close to $88 billion after posting a 90% surge in second quarter
Average US gasoline price falls 45 cents to $4.10 per gallon
Biden's Plan to Confiscate Your Cash? (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Sinema took Wall Street money while killing tax on investors
The Day of Financial Reckoning Is Near (Ad)
Shelling kills 1 in Ukraine; Russia wants nuke plant pledges
High oil prices help Saudi Aramco earn $88B in first half
Ship carrying grain for hungry Ethiopia leaves Ukraine
Trading Millionaire Reveals, “2008 Was My Most Profitable Year” (Ad)
Saudi Aramco's profits already $88B as oil prices stay high
Saudi oil company Aramco's half-year profits reach close to $88 billion after posting a 90% surge in second quarter
Average US gasoline price falls 45 cents to $4.10 per gallon
Biden's Plan to Confiscate Your Cash? (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Sinema took Wall Street money while killing tax on investors
The Day of Financial Reckoning Is Near (Ad)
Shelling kills 1 in Ukraine; Russia wants nuke plant pledges
High oil prices help Saudi Aramco earn $88B in first half
Ship carrying grain for hungry Ethiopia leaves Ukraine
Trading Millionaire Reveals, “2008 Was My Most Profitable Year” (Ad)
Saudi Aramco's profits already $88B as oil prices stay high
Saudi oil company Aramco's half-year profits reach close to $88 billion after posting a 90% surge in second quarter
Average US gasoline price falls 45 cents to $4.10 per gallon
Biden's Plan to Confiscate Your Cash? (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Sinema took Wall Street money while killing tax on investors
The Day of Financial Reckoning Is Near (Ad)
Shelling kills 1 in Ukraine; Russia wants nuke plant pledges
High oil prices help Saudi Aramco earn $88B in first half
Ship carrying grain for hungry Ethiopia leaves Ukraine
Trading Millionaire Reveals, “2008 Was My Most Profitable Year” (Ad)
Saudi Aramco's profits already $88B as oil prices stay high
Saudi oil company Aramco's half-year profits reach close to $88 billion after posting a 90% surge in second quarter
Average US gasoline price falls 45 cents to $4.10 per gallon
Biden's Plan to Confiscate Your Cash? (Ad)
OTCMKTS:HLUYY

H. Lundbeck A/S - HLUYY Stock Forecast, Price & News

$22.00
0.00 (0.00%)
(As of 08/9/2022)
Add
Compare
Today's Range
$22.00
$24.00
50-Day Range
$11.25
$24.79
52-Week Range
$10.00
$31.55
Volume
7,539 shs
Average Volume
1,091 shs
Market Capitalization
$21.91 billion
P/E Ratio
25.00
Dividend Yield
0.89%
Price Target
$72.00

H. Lundbeck A/S MarketRank™ Forecast

Analyst Rating
Hold
2.40 Rating Score
Upside/​Downside
227.3% Upside
$72.00 Price Target
Short Interest
Healthy
0.00% of Shares Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
35.71%
From $2.10 to $2.85 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.56 out of 5 stars

HLUYY stock logo

About H. Lundbeck A/S (OTCMKTS:HLUYY) Stock

H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat depression/schizophrenia. It also provides Azilect for treating Parkinson's disease; Cipralex/Lexapro for depression; Ebixa to treat Alzheimer's disease; Onfi for Lennox-Gastaut syndrome; Sabril for treating epilepsy; and Xenazine for chorea associated with Huntington's disease, as well as other products. The company sells its products primarily to distributors of pharmaceuticals, pharmacies, and hospitals. It has a partnership agreement with Verantos to focus on a study to enable real-world evidence in support of migraine therapy; and collaboration with Rgenta Therapeutics, Inc. The company was founded in 1915 and is headquartered in Valby, Denmark.

Receive HLUYY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for H. Lundbeck A/S and its competitors with MarketBeat's FREE daily newsletter.

HLUYY Stock News Headlines

H. Lundbeck AS ADR (HLUYY)
H. Lundbeck A/S ADR
Global Generic Drugs Market to Reach $507.8 Billion by 2026
H. Lundbeck A/S (HLUYY)
See More Headlines
Receive HLUYY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for H. Lundbeck A/S and its competitors with MarketBeat's FREE daily newsletter.

HLUYY Company Calendar

Last Earnings
11/04/2015
Today
8/14/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Private households
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:HLUYY
CIK
N/A
Employees
5,348
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$72.00
High Stock Price Forecast
$163.00
Low Stock Price Forecast
$35.00
Forecasted Upside/Downside
+227.3%
Consensus Rating
Hold
Rating Score (0-4)
2.40
Research Coverage
5 Analysts

Profitability

Net Income
$209.69 million
Pretax Margin
7.83%

Debt

Sales & Book Value

Annual Sales
$2.59 billion
Cash Flow
$3.36 per share
Book Value
$14.60 per share

Miscellaneous

Free Float
N/A
Market Cap
$21.91 billion
Optionable
Not Optionable
Beta
0.68

Key Executives

  • Dr. Deborah Dunsire M.D. (Age 60)
    Pres & CEO
    Comp: $7.16M
  • Mr. Jacob Tolstrup (Age 50)
    Exec. VP of Commercial Operations & Chief Commercial Officer
    Comp: $888.17k
  • Mr. Lars Bang (Age 60)
    Exec. VP of Product Devel. & Supply
    Comp: $915.5k
  • Dr. Per Johan Luthman (Age 63)
    Exec. VP of R&D
    Comp: $901.84k
  • Mr. Bjorn R. Mogensen
    Sr. VP Group Fin.
  • Dr. Tarek Samad Ph.D.
    Sr. VP & Head of Research
  • Mr. Palle Holm Olesen
    Chief Specialist & VP of Investor Relations
  • Ms. Elise Hauge (Age 55)
    Exec. VP of People & Communication
  • Mr. Ole Chrintz (Age 64)
    Sr. VP of International Markets
  • Mr. Keld Flintholm Jorgensen (Age 51)
    Exec. VP of Corp. Strategy & Bus. Devel.













HLUYY Stock - Frequently Asked Questions

Should I buy or sell H. Lundbeck A/S stock right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for H. Lundbeck A/S in the last year. There are currently 1 sell rating, 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" HLUYY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HLUYY, but not buy additional shares or sell existing shares.
View HLUYY analyst ratings
or view top-rated stocks.

What is H. Lundbeck A/S's stock price forecast for 2022?

5 Wall Street analysts have issued 12 month target prices for H. Lundbeck A/S's stock. Their HLUYY share price forecasts range from $35.00 to $163.00. On average, they anticipate the company's share price to reach $72.00 in the next year. This suggests a possible upside of 227.3% from the stock's current price.
View analysts price targets for HLUYY
or view top-rated stocks among Wall Street analysts.

How have HLUYY shares performed in 2022?

H. Lundbeck A/S's stock was trading at $25.19 at the beginning of the year. Since then, HLUYY shares have decreased by 12.7% and is now trading at $22.00.
View the best growth stocks for 2022 here
.

Are investors shorting H. Lundbeck A/S?

H. Lundbeck A/S saw a decrease in short interest during the month of July. As of July 15th, there was short interest totaling 200 shares, a decrease of 80.0% from the June 30th total of 1,000 shares. Based on an average daily volume of 6,000 shares, the short-interest ratio is presently 0.0 days.
View H. Lundbeck A/S's Short Interest
.

How were H. Lundbeck A/S's earnings last quarter?

H. Lundbeck A/S (OTCMKTS:HLUYY) released its quarterly earnings data on Wednesday, November, 4th. The company reported $0.17 earnings per share for the quarter, beating the consensus estimate of $0.01 by $0.16. The company had revenue of $547.05 million for the quarter, compared to the consensus estimate of $514.82 million. H. Lundbeck A/S had a net margin of 6.74% and a trailing twelve-month return on equity of 13.74%.

How often does H. Lundbeck A/S pay dividends? What is the dividend yield for H. Lundbeck A/S?

H. Lundbeck A/S announced a dividend on Saturday, March 19th. Stockholders of record on Friday, March 25th will be given a dividend of $0.2044 per share on Tuesday, April 5th. This represents a dividend yield of 0.85%. The ex-dividend date is Thursday, March 24th.
Read our dividend analysis for HLUYY
.

Is H. Lundbeck A/S a good dividend stock?

H. Lundbeck A/S (OTCMKTS:HLUYY) pays an annual dividend of $0.20 per share and currently has a dividend yield of 0.89%. The dividend payout ratio is 22.73%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, HLUYY will have a dividend payout ratio of 7.02% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for HLUYY.

What is H. Lundbeck A/S's stock symbol?

H. Lundbeck A/S trades on the OTCMKTS under the ticker symbol "HLUYY."

How do I buy shares of H. Lundbeck A/S?

Shares of HLUYY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is H. Lundbeck A/S's stock price today?

One share of HLUYY stock can currently be purchased for approximately $22.00.

How much money does H. Lundbeck A/S make?

H. Lundbeck A/S (OTCMKTS:HLUYY) has a market capitalization of $21.91 billion and generates $2.59 billion in revenue each year. The company earns $209.69 million in net income (profit) each year or $0.88 on an earnings per share basis.

How many employees does H. Lundbeck A/S have?

The company employs 5,348 workers across the globe.

How can I contact H. Lundbeck A/S?

H. Lundbeck A/S's mailing address is Ottiliavej 9 Valby, Copenhagen G7, 2500. The official website for the company is www.lundbeck.com. The company can be reached via phone at (453) 630-1311, via email at palo@lundbeck.com, or via fax at 45-3630-1940.

This page (OTCMKTS:HLUYY) was last updated on 8/14/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.